Salesforce (CRM) is set to report fiscal third-quarter results tomorrow after the close of trading, and Wedbush Securities is ...

Investing.com -- Wedbush analysts expect tech stocks to end the year strongly with a “Santa rally,” citing positive catalysts ...

Stellantis' next CEO faces a mountain of challenges, including overpriced vehicles with little demand, EVs arriving as the ...

Judge Kathleen McCormick described the electric car maker’s legal arguments as ‘creative’ but ‘fatally flawed’ ...

Major technology stocks are positioned for a strong year-end rally as artificial intelligence initiatives accelerate and ...

Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after ...

The Stellantis 2024 roller coaster hit a new low with CEO Carlos Tavares’s abrupt resignation. Here are three areas a new CEO ...

Some panned the billionaire for overspending on Twitter, but the platform is winning him favor with Donald Trump and ...

Stellantis NV CEO Carlos Tavares resigned Sunday amid the automaker’s recent declining profits, sharply falling sales this ...

Wedbush has assumed coverage of Voyager Therapeutics (NASDAQ:VYGR) with an outperform rating, highlighting the company’s TRACER platform. The investment firm said it believes TRACER alone should ...

Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) is one of the best stocks to buy for long term growth. The ...

The $7 billion RIA welcomes a seasoned professional to help scale the business and draw talent across its private-client and ...